Absorption and efficacy of miconazole nitrate 0.25% ointment in infants with diaper dermatitis.

Abstract

BACKGROUND:

The potential for toxicity from systemic absorption of topical miconazole in infants is a concern.

OBJECTIVE:

To assess the relative safety of 0.25% miconazole based on the amount absorbed through the skin of infants with diaper dermatitis after multiple applications.

METHODS:

Of 24 infants with moderate to severe diaper dermatitis, 19 received 0.25% miconazole nitrate ointment and 5 received 2% miconazole nitrate cream for 7 days at each diaper change and after bathing. Blood samples were collected prior to treatment and after 7 days.

RESULTS:

In the 0.25% treatment group, blood concentrations of miconazole were nondetectable (< 1 ng/mL) in 83% (15/18) and minimal (3.0 to 3.8 ng/mL) in 17% (3/18). Samples were missing for one patient. For the 5 infants in the 2% treatment group, miconazole concentration was nondetectable in 20% (1/5) and less than 7.4 ng/mL in 4 infants. No adverse events were noted.

CONCLUSIONS:

Systemic absorption of 0.25% miconazole nitrate ointment was minimal, demonstrating its safety in the treatment of moderate to severe diaper dermatitis.

• Authors: Lawrence F Eichenfield, Melissa L Bogen
• Journal: Journal of drugs in dermatology : JDD (J Drugs Dermatol) Vol. 6 Issue 5 Pg. 522-6 (May 2007) ISSN: 1545-9616 [Print] United States
• PMID: 17679187 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antifungal Agents
• Ointments
• Miconazole

Topics

• Antifungal Agents (administration & dosage, adverse effects, pharmacokinetics)
• Diaper Rash (drug therapy, etiology, metabolism)
• Female
• Gastrointestinal Diseases (complications)
• Humans
• Infant
• Male
• Miconazole (administration & dosage, adverse effects, pharmacokinetics)
• Ointments
• Severity of Illness Index
• Skin Absorption
• Treatment Outcome